Tussin Dm Cough And Chest Congestion Liquid
NDC Package 49580-0385-2
Package Information
Tussin Dm Cough And Chest Congestion (dextromethorphan hbr, guaifenesin) liquids is do not take more than 6 doses in any 24-hour periodmeasure only with the dosing cup provided. This formulation utilizes a liquid delivery system. Marketed by P & L Development, Llc, this product is identified by NDC 49580-0385 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1605844 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension
- RxCUI: 1605844 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Suspension
- RxCUI: 1605844 - dextromethorphan HBr 20 MG / guaifenesin 200 MG per 10 ML Oral Suspension
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 49580 - P & L Development, Llc
- 49580-0385 - Tussin Dm Cough And Chest Congestion
- 49580-0385-2 - 118 mL in 1 BOTTLE, PLASTIC
- 49580-0385 - Tussin Dm Cough And Chest Congestion
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49580-0385). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49580-0385-2 identifies a specific commercial package of 118 ml in 1 bottle, plastic of Tussin Dm Cough And Chest Congestion Adult, a human over the counter drug labeled by P & L Development, Llc. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by P & L Development, Llc on March 31, 2015. The current certification is valid through December 31, 2026.
How is this P & L Development, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49580038502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.